In-house roundup: Trump trade war uncertainty; 5G guidance not usable; Senate eligibility hearing takeaways; unitary SPC overview

Email a friend Your name:

Your email:

Please enter a maximum of 5 recipients. Use ; to separate more than one email address.

Recipient email(s):

Recipient name(s):

Email yourself a copy?

04 July 2019 |

Patrick Wingrove, London

Managing IP rounds up the latest news and analysis from patent-focused businesses

Drugs

Trump trade war is “lose-lose situation” for IP in China and the US

With Trump blacklisting Huawei from the US, telecom companies tell Patent Strategy they are fearful that a trade war escalation will affect IP and are uncertain how to prepare for such an outcome. Read More...

Diverging SEP guidelines will have little to no impact on negotiations say stakeholders

Reacting to the publication of new SEP licensing guidance, counsel at Audi, Philips and BSH Home Appliances explain how the documents will affect them and that they would like to see a more united direction emerge. Read more...

Patent eligibility hearings “belied depth of opposition to Section 101 change”

Industry speakers from the Senate IP Subcommittee hearings last month tell Patent Strategy how they thought the inquiry was conducted and what needs to happen next to ensure US innovation is protected. Read more...

Unitary SPCs: How, where and when they could work

Industry sources at the Pharmaceutical Patent Term Extension conference in Munich question the practical details of unitary SPCs, including granting procedure, enforcement, and judicial review. Read more...

Comments

Display this name

Notify me of follow up comments

I have read and agree to the terms & conditions.

{{article|snippet:'title'|removeHtmlTags}}

{{article|fields:'dates'|date:dateArticleFormat}} | {{article|fields:'authors'}}

In-house roundup: Trump trade war uncertainty; 5G guidance not usable; Senate eligibility hearing takeaways; unitary SPC overview

Trump trade war is “lose-lose situation” for IP in China and the US

Diverging SEP guidelines will have little to no impact on negotiations say stakeholders

Patent eligibility hearings “belied depth of opposition to Section 101 change”

Unitary SPCs: How, where and when they could work

Comments

Related Articles

Most read articles

In-house roundup: Clearer Section 112 revisions wanted; orphan drug exclusivity not enough; Commission says SPC waiver benefits all; Article 3d wording examined

Henry Carr: “I would never have had a day like that as a barrister”

Turkey: Is a public interest compulsory licence on the way?

EPO: Appeal Board vetoes EPC regulation

Germany: Court blocks prior art time travel

Latest Country Updates

EPO: Appeal Board vetoes EPC regulation

Germany: Court blocks prior art time travel

Turkey: Is a public interest compulsory licence on the way?

Russia: Chamber of Patent Disputes cancels design on second attempt

Canada: Two different approaches to patent applications

Patent Q&A sponsored by Wanhuida – Peksung

IP High Court gives new ruling on patent term extension

How to deal with IP enforcement challenges in Indonesia

Belgium - The (too) effective Belgian descriptive seizures

A guide to patents in Africa

Supplements

Future of IP – Artificial Intelligence 2019

Turkey IP Focus 2019

China IP Focus 2019

Mexico

Americas IP Focus 2018

About Managing IP

My Managing IP

Resources

Site Policies

In-house roundup: Trump trade war uncertainty; 5G guidance not usable; Senate eligibility hearing takeaways; unitary SPC overview

Comments

Related Articles

Most read articles

Latest Country Updates

Supplements

Welcome to Managing Intellectual Property